Jonathan Higbee's picture

HIV Vaccine Advances Following Successful Canadian Trial

Researchers behind the Sumagen AIDS vaccine have announced a successful phase 1 trial in humans and the advancement of the vaccine to the next stage. Exciting news!

From a press release:

Sumagen Canada Inc and Western University announced today that the Phase I Clinical Trial (SAV CT 01) of the first and only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H) has been successfully completed with no adverse effects in all patients. Antibody production was also boosted after vaccination. 

Developed by Dr. Chil-Yong Kang and his team at Western's Schulich School of Medicine & Dentistry, with the support of Sumagen Canada, the vaccine (SAV001-H) holds tremendous promise for success in the final phases of clinical testing now that the first hurdle has been accomplished. It is the only HIV vaccine developed in Canada currently in clinical trial, and one of only a few in the world. This vaccine is the first genetically modified killed whole virus vaccine (SAV001-H) in human clinical trial to evaluate its safety, tolerability and immune responses. The human clinical trial was initiated in March 2012 and completed in August 2013. This trial was a randomized, observer-blinded, placebo-controlled study of killed whole HIV-1 vaccine (SAV001-H) following intramuscular (IM) administration. HIV-infected, asymptomatic men and women, 18 to 50 years of age, have been enrolled in this study and randomized into two treatment groups to administer killed whole HIV-1 vaccine (SAV001-H) or placebo. 

...

SAV001-H is the first genetically modified killed whole virus vaccine (SAV001-H) in human clinical trial and proving its safety was the major concern for going forward for next steps. With these  encouraging results from the Phase I Clinical Trial, Sumagen is confident  in developing SAV001-H as the first preventative HIV vaccine for saving millions of lives and is now preparing for the next phases of trials to show the immunogenicity and efficacy.

Sumagen anticipates not only having the first HIV vaccine in market but also the eradication of HIV/AIDS for human beings.

Mr. Jung-Gee Cho, the CEO of Sumagen Co. Ltd. says, "Even though Sumagen has struggled and spent a much longer time to overcome manufacturing difficulties and to meet the U.S. FDA's requirements, we have accomplished successfully Phase I Clinical Trial of SA001-H and proven that there is no safety concern of SAV001-H in human administration. We are now prepared to take the next steps towards Phase II and Phase III clinical trials. We are opening the gate to pharmaceutical companies, government, and charity organization for collaboration to be one step closer to the first commercialized HIV vaccine."

 

Comments

HI My Name is NANCY, I wish to share my
testimonies with the
general public about what this man called Dr LAWCY
of( drlawcyspellhome@gmail.com ] has just done for me , this man has just did what I thought nobody will ever do for me, i was HIV positive when one of my family friend introduce this man to me, I never believed that great DR LAWCY could do this, when I contacted him on this same issue on ground, he casted some spell for me and gave me some parcel to drink, now I am so happy to say that the virus I was having In my body have left me.
All thanks to DR LAWCY. If you are out there passing through this same kind of
problems you can
contact him today on his mail ( drlawcyspellhome@gmail.com )
and he will also help
you as well with his great spell caster, THANKS BE TO DR LAWCY....

I would like to get more information about HIV vaccine advances please

Add new comment